Publications of Yvonne Genzel
All genres
Journal Article (96)
2023
Journal Article
120 (9), pp. 2639 - 2657 (2023)
Process intensification strategies toward cell culture‐based high‐yield production of a fusogenic oncolytic virus. Biotechnology and Bioengineering
Journal Article
11, 1076524 (2023)
Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactors. Frontiers in Bioengineering and Biotechnology 2022
Journal Article
106, pp. 4945 - 4961 (2022)
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures. Applied Microbiology and Biotechnology
Journal Article
259, 104544 (2022)
Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Journal of Proteomics
Journal Article
11 (22), 3634 (2022)
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading. Cells
Journal Article
10 (2), 249 (2022)
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines
Journal Article
12 (3), 239 (2022)
Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites 2021
Journal Article
118 (10), pp. 3996 - 4013 (2021)
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering
Journal Article
118 (12), pp. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering
Journal Article
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal
Journal Article
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology
Journal Article
105, pp. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology
Journal Article
105 (1), pp. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology
Journal Article
9 (7), 706 (2021)
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor. Vaccines
Journal Article
105 (5), pp. 1861 - 1874 (2021)
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Applied Microbiology and Biotechnology
Journal Article
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology
Journal Article
288 (16), pp. 4869 - 4891 (2021)
Comprehensive N‐glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells. The FEBS Journal
Journal Article
11 (1), 5147 (2021)
Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins. Scientific Reports
Journal Article
105 (4), pp. 1421 - 1434 (2021)
High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells. Applied Microbiology and Biotechnology 2020
Journal Article
8, 672 (2020)
Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode. Frontiers in Bioengineering and Biotechnology